
Investing.com – Israel stocks were higher after the close on Sunday, as gains in the Oil&Gas, Insurance and Real Estate sectors led shares higher.
At the close in Tel Aviv, the TA 35 rose 0.68%.
The best performers of the session on the TA 35 were Teva Pharmaceutical Industries Ltd (TASE:TEVA), which rose 3.82% or 131.00 points to trade at 3,559.00 at the close. Meanwhile, Israel Corp (TASE:ILCO) added 3.49% or 3,720.00 points to end at 110,400.00 and ICL Israel Chemicals Ltd (TASE:ICL) was up 3.29% or 75.00 points to 2,355.00 in late trade.
The worst performers of the session were Ormat Technologies (TASE:ORA), which fell 4.82% or 1,430.00 points to trade at 28,210.00 at the close. Newmed Energy LP (TASE:NWMDp) declined 2.14% or 24.00 points to end at 1,096.00 and Strauss Group (TASE:STRS) was down 1.41% or 122.00 points to 8,547.00.
Rising stocks outnumbered declining ones on the Tel Aviv Stock Exchange by 305 to 163 and 33 ended unchanged.
Shares in Ormat Technologies (TASE:ORA) fell to 52-week lows; down 4.82% or 1,430.00 to 28,210.00.
Crude oil for September delivery was up 1.34% or 1.09 to $82.64 a barrel. Elsewhere in commodities trading, Brent oil for delivery in October rose 1.19% or 1.01 to hit $86.15 a barrel, while the December Gold Futures contract rose 0.48% or 9.40 to trade at $1,978.20 a troy ounce.
USD/ILS was down 0.63% to 3.65, while EUR/ILS unchanged 0.03% to 4.02.
The US Dollar Index Futures was down 0.51% at 101.83.
Begin trading today! Create an account by completing our form
At One Financial Markets we are committed to safeguarding your privacy.
Please see our Privacy Policy for details about what information is collected from you and why it is collected. We do not sell your information or use it other than as described in the Policy.
Please note that it is in our legitimate business interest to send you certain marketing emails from time to time. However, if you would prefer not to receive these you can opt-out by ticking the box below.
Alternatively, you can use the unsubscribe link at the bottom of the Demo account confirmation email or any subsequent emails we send.
By completing the form and downloading the platform you agree with the use of your personal information as detailed in the Policy.